Fresenius Medical Care AGFMS

NYSEHealthcareServices-Misc Health & Allied Services, NEC
Price (close)
$22.35
Market cap
$11.9B
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
3.90%
1-year total return
-7.7%
Net margin
—
Revenue growth
—
Debt / equity
—

What Fresenius Medical Care AG does.

Fresenius Medical Care is the world’s leading provider of products and services for individuals with kidney diseases based on publicly reported revenue. As a vertically integrated medical technology (MedTech) and healthcare service company, Fresenius Medical Care combines medical device engineering and manufacturing expertise with comprehensive patient care.

The incidence of kidney disease is increasing worldwide. A significant rise in the drivers of kidney disease, such as obesity, diabetes, and hypertension, has elevated it to a global public health epidemic. According to estimates, the number of people requiring dialysis globally is increasing at a rate of 4% to 5% each year and is expected to reach around 7 M people by 2035.

Our care models, technologies, and partnerships position us to meet the growing demand for life-sustaining services and products that are vital to millions of people living with kidney disease worldwide. Kidney patients require therapy, pharmaceuticals, medical technologies, and products that meet their individual needs and preferences, regardless of where they receive treatment, whether in one of our treatment centers, a hospital setting, at home, or when traveling.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue——————
Net income——————
Free cash flow——————

More on FMS.

Figures from Fresenius Medical Care AG's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.